Accounts Payable and Accrued Expenses

6 Months Ended

Jun. 30, 2024

11. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consisted of the following:


	June 30,		December 31,
(In thousands)	2024		2023
Accounts payable	$	104,747	$	65,649
Accrued compensation		49,390		83,107
Accrued other		85,637		91,805
Total accounts payable and accrued expenses	$	239,774	$	240,561

A summary of the Company’s current provision for sales discounts, allowances and reserves was as follows:


	June 30,		December 31,
(In thousands)	2024		2023
Medicaid rebates	$	212,995	$	213,845
Product discounts		16,207		15,121
Medicare Part D		18,246		20,569
Other		16,009		14,106
Total accrued sales discounts, allowances and reserves	$	263,457	$	263,641

Included in accounts payable was approximately $50.3 million and $34.5 million of amounts payable related to state U.S. Medicaid rebates as of June 30, 2024 and December 31, 2023, respectively.